ArticleStroke (Hoboken, N.J.)2025
Safety and Efficacy of the Red43 Aspiration Catheter for Distal Medium Vessel Occlusion Stroke.
Article in Stroke (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial: Distal, medium vessel occlusion stroke: epidemiology, diagnostics, treatment options, and outcome prediction.Frontiers in stroke · 2026Article
- Safety and Efficacy of the Red43 Aspiration Catheter for Distal Medium Vessel Occlusion Stroke.Stroke (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The optimal therapeutic approach for acute ischaemic stroke due to distal medium vessel occlusion remains uncertain. The use of endovascular therapy in this context is restricted by challenges in navigating distal vessels with available devices. This study aimed to assess the safety and effectiveness of the Red43 aspiration catheter (Penumbra, Alameda, CA) in patients experiencing stroke due to distal medium vessel occlusion. Methods: A retrospective analysis was conducted on consecutive patients who underwent mechanical thrombectomy for acute ischemic stroke at a single high-volume comprehensive stroke center from April 2023 to March 2024. Patients were included if they had an acute ischemic stroke with distal medium vessel occlusion and were treated using the Red43 aspiration catheter. Results: The Red43 aspiration catheter successfully reached the occlusion site in 94% of cases. modified treatment in cerebral ischemia 2b-3 reperfusion was achieved in 77% of patients following initial use of the Red43 catheter, whereas modified treatment in cerebral ischemia 2c-3 reperfusion was observed in 66%. No cases of symptomatic intracranial hemorrhage, vessel perforation, or dissection occurred during the procedure. Conclusion: The Red43 aspiration catheter demonstrated a high rate of successful reperfusion with a favorable safety profile in the treatment of distal medium vessel occlusion stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.